1096875-61-4

Usage

Uses

Used in Pharmaceutical Applications:
BCPMF is used as a potential pharmaceutical agent for its antimicrobial properties, which can be beneficial in the development of new antibiotics to combat resistant bacteria. Its anti-inflammatory effects also make it a candidate for the treatment of various inflammatory conditions.
Used in Medicinal Chemistry:
As a novel psychoactive substance, BCPMF is used in the field of medicinal chemistry for research purposes. Its potential applications in this area may include the development of new therapies for neurological or psychiatric disorders, pending further research and understanding of its properties.
Used in Chemical Research:
BCPMF is also used as a subject of study in chemical research, where its complex molecular structure and diverse biological activities can provide insights into the development of new compounds with specific therapeutic targets or mechanisms of action.

Upstream product

• 496-16-2 2.3-dihydrobenzofuran 
• 21739-92-4 5-bromo-2-chlorobenzoic acid 

Downstream Products

• 1282733-55-4 (5-bromo-2-chloro-phenyl)-(2,3-dihydrobenzofuran-5-yl)methanol 
• 1291094-09-1 (2S,3R,4R,5S,6R)-2-[4-chloro-3-(2,3-dihydro-benzofuran-5-ylmethyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 
• 1358580-72-9 [(1S,2S,3S,4R,5S)-2,3,4-tribenzyloxy-5-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-6,8-dioxabicyclo[3.2.1]octan-1-yl]methanol 
• 1358580-71-8 [(3S,4S,5R,6S)-3,4,5-tribenzyloxy-6-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-2-(hydroxymethyl)-6-methoxy-tetrahydropyran-2-yl]methanol 
• 1358580-65-0 (2S,3S,4S,5R,6S)-3,4,5-tribenzyloxy-6-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-6-methoxy-tetrahydropyran-2-carbaldehyde 
• 1358580-64-9 [(2R,3R,4S,5R,6S)-3,4,5-tribenzyloxy-6-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-6-methoxy-tetrahydropyran-2-yl]methanol 
• 1358580-62-7 [[(2R,3R,4S,5R,6S)-3,4,5-tribenzyloxy-6-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-6-methoxy-tetrahydropyran-2-yl]tert-butyl-dimethyl-methoxy]silane 
• 1358580-58-1 (2S,3R,4S,5S,6R)-6-[(tert-butyl(dimethyl)silyl)oxymethyl]-2-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-2-methoxy-tetrahydropyran-3,4,5-triol 
• 1358580-57-0 (2S,3R,4S,5S,6R)-2-[4-chloro-3-(2,3-dihydrobenzofuran-5-ylmethyl)phenyl]-6-(hydroxymethyl)-2-methoxy-tetrahydropyran-3,4,5-triol 

Relevant academic research and scientific papers

Bicyclic derivative of heterocyclic glucoside as well as preparation method and application of bicyclic derivative

The invention relates to a bicyclic derivative of heterocyclic glucoside as well as a preparation method and application of the bicyclic derivative, in particular to a compound shown in a formula I, a stereoisomer or pharmaceutically acceptable salt or es

C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

C-aryl glucoside derivatives, preparation processes and pharmaceutical uses thereof are disclosed. In particular, C-aryl glucoside derivatives represented by formula (I), with each substituent defined in the application, pharmaceutically acceptable salts or stereoisomers thereof, their preparation methods, and pharmaceutical compositions containing the derivatives as well as their uses as therapeutic agents, particularly as sodium-dependent glucose cotransporter (SGLT)-1 inhibitors, are disclosed.